Scientists test CRISPR gene editing on 2 U.S. cancer patients
CRISPR, a new technique for editing DNA, is being tested in clinical trials for the first time in the U.S., NPR reported on Tuesday.
After a few studies based in China on using the gene-editing technology to treat disease, two American cancer patients are being treated with CRISPR for their cancer. The patients, being treated as part of a study at the University of Pennsylvania, had both "relapsed after undergoing standard treatment." One patient was diagnosed with multiple myeloma, a form of cancer that affects plasma cells in the blood; the other was diagnosed with sarcoma, a tumor that affects connective tissue in the body.
In addition to the University of Pennsylvania trial, several other studies have also been approved in the U.S., Canada, and Europe, in order to test the efficiency of the CRISPR method in treating various diseases.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Many scientists are hopeful that this will mark a new era in disease treatment: "2019 is the year when the training wheels come off," and we will better understand "what CRISPR can really do for the world," said Fyodor Urnov, a gene-editing scientist. Read more about CRISPR at NPR.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Shivani is the editorial assistant at TheWeek.com and has previously written for StreetEasy and Mic.com. A graduate of the physics and journalism departments at NYU, Shivani currently lives in Brooklyn and spends free time cooking, watching TV, and taking too many selfies.
-
What can Elon Musk's cost-cutting task force actually cut?
Talking Points A $2 trillion goal. And big obstacles in the way.
By Joel Mathis, The Week US Published
-
Her Lotus Year: Paul French's new biography sets lurid rumours straight
The Week Recommends Wallis Simpson's year in China is less scandalous, but 'more interesting' than previously thought
By The Week UK Published
-
Today's political cartoons - November 21, 2024
Cartoons Thursday's cartoons - wild cards, wild turkeys, and more
By The Week US Published
-
Dark energy data suggest Einstein was right
Speed Read Albert Einstein's 1915 theory of general relativity has been proven correct, according to data collected by the Dark Energy Spectroscopic Instrument
By Peter Weber, The Week US Published
-
New DNA tests of Pompeii dead upend popular stories
Speed Read An analysis of skeletal remains reveals that some Mount Vesuvius victims have been wrongly identified
By Peter Weber, The Week US Published
-
NASA's Europa Clipper blasts off, seeking an ocean
Speed Read The ship is headed toward Jupiter on a yearslong journey
By Peter Weber, The Week US Published
-
Detailed map of fly's brain holds clues to human mind
Speed Read This remarkable fruit fly brain analysis will aid in future human brain research
By Peter Weber, The Week US Published
-
Blind people will listen to next week's total eclipse
Speed Read While they can't see the event, they can hear it with a device that translates the sky's brightness into music
By Peter Weber, The Week US Published
-
Melting polar ice is messing with global timekeeping
Speed Read Ice loss caused by climate change is slowing the Earth's rotation
By Peter Weber, The Week US Published
-
An amphibian that produces milk?
speed read Caecilians, worm-like amphibians that live underground, produce a milk-like substance for their hatchlings
By Peter Weber, The Week US Published
-
Jupiter's Europa has less oxygen than hoped
speed read Scientists say this makes it less likely that Jupiter's moon harbors life
By Peter Weber, The Week US Published